« Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase », Can Dermatol Today, vol. 7, nᵒ 3, p. 4–10, sept. 2026, doi: 10.58931/cdt.2026.73167.